NS · Healthcare

Genomic Valley Biotech Ltd (539206)

Pharmaceuticals & Biotechnology

Genomic Valley Biotech Ltd (539206) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $107.20M, P/E ratio is 351.10, net margin is 20.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 539206

Market cap

$107.20M

P/E ratio

351.10

Net margin

20.8%

Genomic Valley Biotech Ltd (539206) — FAQ

What is Genomic Valley Biotech Ltd's market cap?

Genomic Valley Biotech Ltd (539206) has a reported market cap of $107.20M (data as of 2026-07-10).

What is 539206's P/E ratio?

The price-to-earnings (P/E) ratio for Genomic Valley Biotech Ltd (539206) is 351.10 (data as of 2026-07-10).

Does Genomic Valley Biotech Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Genomic Valley Biotech Ltd (539206). Check the MyAverix Finance app for the latest dividend data.

What sector is Genomic Valley Biotech Ltd in?

Genomic Valley Biotech Ltd (539206) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is 539206 listed on?

539206 is listed on NS.

What is Genomic Valley Biotech Ltd's net margin?

Genomic Valley Biotech Ltd (539206) reports a net margin of 20.8% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)